Literature DB >> 26627223

Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.

J Grams1, W Timothy Garvey2.   

Abstract

Weight loss, whether achieved by lifestyle intervention, pharmacotherapy, or bariatric surgery, is highly effective as a primary interventional strategy in both the prevention and treatment of type 2 diabetes. In high-risk patients with prediabetes and/or metabolic syndrome, weight loss effectively prevents progression to type 2 diabetes mellitus (T2DM) and improves cardiovascular risk factors. These benefits are the result of improvements in insulin resistance, which is central to the pathophysiology of cardiometabolic disease. In patients with T2DM, weight loss improves glycemia, while reducing the need for conventional glucose-lowering medicines, by affecting all three processes that produce and sustain the hyperglycemic state, namely via increments in peripheral insulin sensitivity with improvements in insulin signal transduction at the cellular level, more robust insulin secretory responses, and reduced rates of hepatic glucose production. In both nondiabetic and diabetic subjects, hypocaloric feeding (e.g., treatment with very low-calorie diet or bariatric surgery) produces a rapid improvement in insulin sensitivity due to mobilization of fat from the intramyocellular, intrahepatocellular, and intra-abdominal compartments, and via a more long-term mechanism that correlates with the loss of total body fat. In diabetes, by improving glycemia, weight loss also enhances glucose homeostasis by reversing the defects in insulin action and secretion attributable to glucose toxicity. Regardless of the therapeutic approach, weight loss of ∼ 10 % maximally prevents future diabetes in patients with prediabetes or metabolic syndrome. In T2DM, greater degrees of weight loss lead to progressive improvements in glucose homeostasis. Therefore, when accompanied by greater weight loss, the metabolic benefits following bariatric surgery are generally more pronounced than those achieved following lifestyle and medical treatment. In addition, the mechanisms by which bariatric operations improve diabetes may include both weight-dependent and weight-independent mechanisms, and the latter may involve changes in gut hormones, bile acids, or gut microflora.

Entities:  

Keywords:  Bariatric surgery; Diabetes; Lifestyle intervention; Mechanism of action; Metabolic syndrome; Obesity; Obesity medications; Prediabetes; Weight loss

Mesh:

Substances:

Year:  2015        PMID: 26627223     DOI: 10.1007/s13679-015-0155-x

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  161 in total

1.  Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Authors:  Florencia Halperin; Su-Ann Ding; Donald C Simonson; Jennifer Panosian; Ann Goebel-Fabbri; Marlene Wewalka; Osama Hamdy; Martin Abrahamson; Kerri Clancy; Kathleen Foster; David Lautz; Ashley Vernon; Allison B Goldfine
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

2.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 5.  Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

Authors:  M Diamant; E E Blaak; W M de Vos
Journal:  Obes Rev       Date:  2010-08-26       Impact factor: 9.213

6.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

7.  Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss.

Authors:  J C Guare; R R Wing; A Grant
Journal:  Obes Res       Date:  1995-07

8.  The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

Authors:  W T Garvey; J M Olefsky; J Griffin; R F Hamman; O G Kolterman
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

Review 9.  Gut microflora as a target for energy and metabolic homeostasis.

Authors:  Patrice D Cani; Nathalie M Delzenne
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-11       Impact factor: 4.294

10.  Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

Authors:  Johan Arnlöv; Erik Ingelsson; Johan Sundström; Lars Lind
Journal:  Circulation       Date:  2009-12-28       Impact factor: 29.690

View more
  25 in total

1.  MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study.

Authors:  Philip D Ambery; Sebastian Klammt; Maximillian G Posch; Marcella Petrone; Wenji Pu; Cristina Rondinone; Lutz Jermutus; Boaz Hirshberg
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

2.  Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.

Authors:  Arwa Younis; Anan Younis; Boaz Tzur; Yael Peled; Nir Shlomo; Ilan Goldenberg; Enrique Z Fisman; Alexander Tenenbaum; Robert Klempfner
Journal:  Cardiovasc Diabetol       Date:  2016-10-28       Impact factor: 9.951

3.  Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center.

Authors:  Shivanshu Misra; B Deepa Nandhini; S Christinajoice; S Saravana Kumar; S Prabhakaran; C Palanivelu; P Praveen Raj
Journal:  Obes Surg       Date:  2020-07-29       Impact factor: 4.129

Review 4.  Treatment of Obesity: Weight Loss and Bariatric Surgery.

Authors:  Bruce M Wolfe; Elizaveta Kvach; Robert H Eckel
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

5.  Association Between Late Bedtime and Diabetes Mellitus: A Large Community-Based Study.

Authors:  Bin Yan; Yajuan Fan; Binbin Zhao; Xiaoyan He; Jian Yang; Ce Chen; Xiancang Ma
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

6.  Risk Factors for Dementia in Patients With Atrial Fibrillation.

Authors:  Aniqa B Alam; Pamela L Lutsey; Lin Y Chen; Richard F MacLehose; Iris Y Shao; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2022-04-23       Impact factor: 3.133

Review 7.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

Review 8.  The aetiology and molecular landscape of insulin resistance.

Authors:  David E James; Jacqueline Stöckli; Morris J Birnbaum
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-20       Impact factor: 94.444

9.  Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic control and antioxidant status in people with type 2 diabetes; a randomized, double-blind, placebo-controlled study.

Authors:  Hossein Mirmiranpour; Hasan Fallah Huseini; Hoda Derakhshanian; Zohreh Khodaii; Bahareh Tavakoli-Far
Journal:  J Diabetes Metab Disord       Date:  2019-12-23

10.  Anti-hyperglycemic and ameliorative effect of concentrated hot water-infusion of Phragmanthera incana leaves on type 2 diabetes and indices of complications in diabetic rats.

Authors:  Olakunle Sanni; Ochuko L Erukainure; Olajumoke Oyebode; Md Shahidul Islam
Journal:  J Diabetes Metab Disord       Date:  2019-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.